Şirket hakkında

The Algernon drug development program was the brainchild of Dr. Mark Williams, the Company’s CSO, whose innovative approach to drug discovery was developed over many years as senior scientist in the drug development industry. The company and its business model is highly capital efficient and strives to deliver maximum shareholder value.

CA
Bilinmeyen
Bilinmeyen
Doğrulanmamış şirket